产科出血三层风险评估工具与不良结局的相关性
该回顾性队列研究纳入4404例≥14周单胎分娩产妇,按产后出血风险分为低、中、高危组。校正后中危组复合母体出血结局风险显著高于低危组(aRR 1.23,95%CI 1.05-1.43),高危组亦显著升高(aRR 1.51,95%CI 1.31-1.75);复合新生儿不良结局在三组间无显著差异。
要点
- 中危组复合母体出血结局风险较低危组显著升高(aRR 1.23,95%CI 1.05-1.43)。
- 高危组复合母体出血结局风险较低危组显著升高(aRR 1.51,95%CI 1.31-1.75)。
- 复合新生儿不良结局在中危组和高危组与低危组比较均无显著差异。
核心结论
- 尽管被归为高危的产妇中8/10既无出血量≥1000 mL也未输血,但该风险分层可提供复合母体出血结局的信息。
研究设计与样本
- 回顾性队列研究,纳入单中心1年内所有孕周≥14周的单胎分娩产妇。
- 研究期间共4544例分娩,4404例(96.7%)符合纳入标准。
- 产后由研究者按加利福尼亚孕产妇质量护理协作组(经美国妇产科医师学会修改)方案分为低危1745例(39.6%)、中危1376例(31.2%)、高危1283例(29.1%)。
主要发现
- 总体941例(21.4%)发生复合母体出血结局,低危组285例(16.4%)、中危组319例(23.2%)、高危组337例(26.3%)。
- 低危组95.7%、中危组89.4%、高危组85.3%的产妇既无估计失血量或定量失血量≥1000 mL也未输血。
- 校正后与低危组相比,中危组复合母体出血结局风险显著升高(aRR 1.23,95%CI 1.05-1.43),高危组亦显著升高(aRR 1.51,95%CI 1.31-1.75)。
- 总体366例新生儿(8.4%)发生复合新生儿不良结局,低危组76例(4.2%)、中危组153例(11.3%)、高危组140例(11.1%)。
- 校正后与低危组相比,中危组(aRR 1.27,95%CI 0.97-1.68)和高危组(aRR 1.29,95%CI 0.98-1.68)复合新生儿不良结局均无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines promote stratification for the risk for postpartum hemorrhage among parturients, although the evidence for the associated differential morbidity among the groups remains inconsistent among published reports. OBJECTIVE: Using the California Maternal Quality Care Collaborative schema modified by the American College of Obstetrics and Gynecology, we compared the composite maternal hemorrhagic outcome and the composite neonatal adverse outcome among singletons who were categorized after delivery by the researchers as low-, medium-, or high-risk for postpartum hemorrhage. We hypothesized that the composite outcomes would be significantly different among the individuals in the different 3-tiered categories. STUDY DESIGN: This was a retrospective cohort study of all singleton parturients with a gestational age of at least 14 weeks who delivered at a single site within 1 year. The composite maternal hemorrhagic outcome included any of the following: estimated blood loss ≥1000 mL, use of uterotonics (excluding prophylactic oxytocin) or Bakri balloon, surgical management of postpartum hemorrhage, blood transfusion, hysterectomy, thromboembolism, admission to the intensive care unit, or maternal death. The composite neonatal adverse outcome included Apgar score <7 at 5 minutes, birth injury, bronchopulmonary dysplasia, intraventricular hemorrhage, neonatal seizure, sepsis, ventilation > 6 hrs., brachial plexus palsy, hypoxic-ischemic encephalopathy, or neonatal death. Multivariable Poisson regression models with robust error variance were used to estimate the adjusted relative risks with 95% confidence intervals. RESULTS: Of the 4544 deliveries in the study period, 4404 (96.7%) met the inclusion criteria, and among them, 1745 (39.6%) were categorized as low, 1376 (31.2%) as medium, and 1283 (29.1%) as high risk. Overall, 941 (21.4%) participants experienced the composite maternal hemorrhagic outcome with 285 (16.4%) of those being in the low-risk group, 319 (23.2%) in the medium-risk group, and 337 (26.3%) in the high-risk group. Among all parturients, 95.7% in the low-, 89.4% in the medium-, and 85.3% in the high-risk group neither had an estimated blood loss or a quantified blood loss ≥1000 mL nor were transfused. After multivariable adjustment and when compared with the low-risk group, there was a significantly higher risk for the composite maternal hemorrhagic outcome in the medium-risk group (adjusted relative risk, 1.23; 95% confidence interval, 1.05-1.43) and in the high-risk group (adjusted relative risk, 1.51; 95% confidence interval, 1.31-1.75). Overall, 366 newborns (8.4%) developed the composite neonatal adverse outcome with 76 (4.2%) in of those being in the low-risk group, 153 (11.3%) in the medium-risk group, and 140 (11.1%) in the high-risk group. After multivariable adjustment and when compared with the low-risk group, there were no significant differences in the composite neonatal adverse outcome in the medium- (adjusted relative risk, 1.27; 95% confidence interval, 0.97-1.68) or the high-risk group (adjusted relative risk, 1.29; 95% confidence interval, 0.98-1.68). CONCLUSION: Although 8 of 10 parturients categorized as high risk neither had blood loss ≥1000 mL nor underwent transfusion, the risk stratification provides information regarding the composite maternal hemorrhagic outcome.
引用
- Ghose I, Wiley RL, Ciomperlik HN, et al. Association of adverse outcomes with three-tiered risk assessment tool for obstetrical hemorrhage. Am J Obstet Gynecol MFM. 2023. PMID: 37524259. doi:10.1016/j.ajogmf.2023.101106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。